Association between albumin-to-globulin ratio and the risk of overall survival in advanced non-small cell lung cancer patients with anlotinib treatment: a retrospective cohort study - Chen, Jinzhan; Xie, Congyi; Yang, Yimin; Yang, Shuwen; Huang, Jinxian; Ye, Feiyang; Lin, Zhenyang; Tong, Lin; Liu, Jiaxin (BMC pulmonary medicine, 2023)
Keywords: Albumin; Anlotinib; Cohort analysis; Critical care; Data analysis; Drug therapy; Globulin; Globulins; Growth factors; Immunotherapy; Kinases; Lung cancer; Lung cancer, Non-small cell; Medical prognosis; Metastasis; Non-small cell lung carcinoma; Normal distribution; Overall survival; Patient outcomes; Patients; Prognosis; Pulmonology; Regression analysis; Small cell lung carcinoma; Variables; China; Albumin; Anlotinib; Overall survival; Lung cancer; Globulin